HIV-1 Rev oligomerization is not obligatory in the presence of an extra basic domain

Retrovirology

Volumn 2, Issue , 2005, Pages

  Furnes, Clemens ^a   Arnesen, Thomas ^a   Askjaer, Peter ^b,c   Kjems, Jørgen ^b   Szilvay, Anne Marie ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b AARHUS UNIVERSITY   (Denmark)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; GAG PROTEIN; HYBRID PROTEIN; MESSENGER RNA; MUTANT PROTEIN; OLIGOMER; REGULATOR PROTEIN; REV PROTEIN; REX PROTEIN; STRUCTURAL PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS RNA;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIMERIZATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; INTRON; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEAR LOCALIZATION SIGNAL; OLIGOMERIZATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; REPORTER GENE; RNA SPLICING; STEADY STATE; WILD TYPE; ACTIVE TRANSPORT; ANIMAL; CELL LINE; CELL NUCLEUS; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; CYTOPLASM; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MUTATION; PLASMID;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL LINE; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOPLASM; DIMERIZATION; GENE PRODUCTS, REV; HUMANS; MUTATION; PLASMIDS; RNA, MESSENGER; RNA, VIRAL; TRANSFECTION;

EID: 27444442727     PISSN: 17424690     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-2-39     Document Type: Article

References (47)

1. Malim MH, Hauber J, Fenrick R, Cullen BR: Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature 1988, 335(6186):181-183.
2. Dayton AI, Terwilliger EF, Potz J, Kowalski M, Sodroski JG, Haseltine WA: Cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus. J Acquir Immune Defic Syndr 1988, 1(5):441-452.
3. Malim MH, Cullen BR: HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell 1991, 65(2):241-248.
4. Schwartz S, Felber BK, Pavlakis GN: Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J Virol 1992, 66(1):150-159.
5. Cochrane AW, Jones KS, Beidas S, Dillon PJ, Skalka AM, Rosen CA: Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J Virol 1991, 62:5305-5313.
6. Maldarelli F, Martin MA, Strebel K: Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J Virol 1991, 65(11):5732-5743.
7. Kalland KH, Szilvay AM, Brokstad KA, Saetrevik W, Haukenes G: The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments. Mol Cell Biol 1994, 14(11):7436-7444.
8. Meyer BE, Malim MH: The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev 1994, 8(13):1538-1547.
9. Cochrane AW, Perkins A, Rosen CA: Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function. J Virol 1990, 64:881-885.
10. Malim MH, Hauber J, Le SY, Maizel JV, Cullen BR: The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 1989, 338(6212):254-257.
11. Kjems J, Brown M, Chang DD, Sharp PA: Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element. Proc Natl Acad Sci U S A 1991, 88(3):683-687.
12. Szilvay AM, Brokstad KA, Kopperud R, Haukenes G, Kalland KH: Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants. J Virol 1995, 69(6):3315-3323.
13. Fischer U, Huber J, Bolens WC, Mattaj IW, Luhrmann R: The HIV-1 Rev Activation Domain is a Nuclear Export Signal that Accesses an Export Pathway used by Specific Cellular RNAs. Cell 1995, 82:475-483.
14. Wolff B, Cohen G, Hauber J, Meshcheryakova D, Rabeck C: Nucleocytoplasmic transport of the Rev protein of human immunodeficiency virus type 1 is dependent on the activation domain of the protein. Exp Cell Res 1995, 217(1):31-41.
15. Powell DM, Zhang MJ, Konings DA, Wingfield PT, Stahl SJ, Dayton ET, Dayton AI: Sequence specificity in the higher-order interaction of the Rev protein of HIV-1 with its target sequence, the RRE. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 10(3):317-323.
16. Kjems J, Askjaer P: Rev protein and its cellular partners. Adv Pharmacol 2000, 48:251-298.
17. Kjems J, Calnan BJ, Frankel AD, Sharp PA: Specific binding of a basic peptide from HIV-1 Rev. Embo J 1992, 11(3):1119-1129.
18. Tiley LS, Malim MH, Tewary HK, Stockley PG, Cullen BR: Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. Proc Natl Acad Sci U S A 1992, 89(2):758-762.
19. Cook KS, Fisk GJ, Hauber J, Usman N, Daly TJ, Rusche JR: Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate. Nucleic Acids Res 1991, 19(7):1577-1583.
20. Olsen HS, Cochrane AW, Dillon PJ, Nalin CM, Rosen CA: Interaction of the human immunodeficiency virus type 1 rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. Genes Dev 1990, 4:1357-1364.
21. Brice PC, Kelley AC, Butler PJ: Sensitive in vitro analysis of HIV-1 Rev multimerization. Nucleic Acids Res 1999, 27(10):2080-2085.
22. Zapp ML, Hope TJ, Parslow TG, Green MR: Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proc Natl Acad Sci U S A 1991, 88(17):7734-7738.
23. Hope TJ, McDonald D, Huang XJ, Low J, Parslow TG: Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus. J Virol 1990, 64(11):5360-5366.
24. Madore SJ, Tiley LS, Malim MH, Cullen BR: Sequence requirements for Rev multimerization in vivo. Virology 1994, 202(1):186-194.
25. Bogerd H, Greene WC: Dominant Negative Mutants of Human T-Cell Leukemia Virus Type 1 Rex and Human Immunodeficiency Virus Type 1 Rev Fail to Multimerize In Vivo. J Virol 1993, 67(5):2496-2502.
26. Szilvay AM, Brokstad KA, Boe SO, Haukenes G, Kalland KH: Oligomerization of HIV-1 Rev mutants in the cytoplasm and during nuclear import. Virology 1997, 235(1):73-81.
27. Stauber RH, Afonina E, Gulnik S, Erickson J, Pavlakis GN: Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells. Virology 1998, 251(1):38-48.
28. Gjerdrum C, Stranda A, Szilvay AM: Functional role of the HIV-1 Rev exon I encoded region in complex formation and transdominant inhibition. FEBS Lett 2001, 495(1-2):106-110.
29. Malim MH, Bohnlein S, Hauber J, Cullen BR: Functional dissection of the HIV-1 Rev trans-activator-derivation of a trans-dominant repressor of Rev function. Cell 1989, 58(1):205-214.
30. Thomas SL, Oft M, Jaksche H, Casar G, Heger P. Dobrovnik M, Bevec D, Hauber J: Functional analysis of the human immunodeficiency virus type 1 Rev protein oligomerization interface. J Virol 1998, 72(4):2935-2944.
31. Wolff B, Sanglier JJ, Wang Y: Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem Biol 1997, 4(2):139-147.
32. Felber BK, Derse D, Athanassopoulos A, Campbell M, Pavlakis GN; Cross-activation of the Rex proteins of HTLV-I and BLV and of the Rev protein of HIV-1 and nonreciprocal interactions with their RNA responsive elements. New Biol 1989, 1(3):318-328.
33. Hanly SM, Rimsky LT, Malim MH, Kim JH, Hauber J, Duc Dodon M, Le SY, Maizel JV, Cullen BR, Greene WC: Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements. Genes Dev 1989, 3(10):1534-1544.
34. Dundr M, Leno GH, Hammarskjold ML, Rekosh D, Helga-Maria C, Olson MO: The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein. J Cell Sci 1995, 108 (Pt 8):2811-2823.
35. Truant R, Cullen BR: The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals. MCB 1999, 19(2):1210-1217.
36. Palmeri D, Malim MH: Importin beta can mediate the nuclear import of an arginine-rich nuclear localization signal in the absence of importin alpha. Mol Cell Biol 1999, 19(2):1218-1225.
37. Solomin L, Felber BK, Pavlakis GN: Different sites of interaction for Rev, Tev, and Rex proteins within the Rev-responsive element of human immunodeficiency virus type 1. J Virol 1990, 64(12):6010-6017.
38. Sakai H, Siomi H, Shida H, Shibata R, Kiyomasu T, Adachi A: Functional comparison of transactivation by human retrovirus rev and rex genes. J Virol 1990, 64(12):5833-5839.
39. Kjems J, Frankel AD, Sharp PA: Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev. Cell 1991, 67(1):169-178.
40. Kjems J, Sharp PA: The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assembly. J Virol 1993, 67(8):4769-4776.
41. Takebe Y, Seiki M, Fujisawa J, Hoy P, Yokota K, Arai K, Yoshida M, Arai N: SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol 1988, 8(1):466-472.
42. Holden L: A study of nuclear import of retroviral regulatory proteins using monoclonal antibodies and high efficiency eukaryotic expression vectors. In Department of Molecular Biology Volume candidata scientiarum. Bergen, University of Bergen; 2000:99.
43. Hope TJ, Bond BL, McDonald D, Klein NP, Parslow TG: Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type 1 Rex are functionally interchangeable and share an essential peptide motif. J Virol 1991, 65(11):6001-6007.
44. Hope TJ, Huang XJ, McDonald D, Parslow TG: Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the argininerich motif. Proc Natl Acad Sci U S A 1990, 87(19):7787-7791.
45. Kalland KH, Szilvay AM, Langhoff E, Haukenes G: Subcellular distribution of human immunodeficiency virus type 1 Rev and colocalization of Rev with RNA splicing factors in a speckled pattern in the nucleoplasm. J Virol 1994, 68(3):1475-1485.
46. Valvatne H, Szilvay AM, Helland DE: A monoclonal antibody defines a novel HIV type 1 Tat domain involved in trans-cellular trans-activation. AIDS Res Hum Retroviruses 1996, 12(7):611-619.
47. Ferns RB, Tedder RS, Weiss RA: Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation. J Gen Virol 1987, 68 (Pt 6):1543-1551.